Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,655 | 667 | 99.9% |
| Education | $13.97 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,910 | 82 | $0 (2024) |
| Novo Nordisk Inc | $1,269 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,227 | 61 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,188 | 48 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,074 | 76 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,017 | 39 | $0 (2024) |
| Lilly USA, LLC | $880.53 | 33 | $0 (2024) |
| Amgen Inc. | $801.26 | 23 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $576.09 | 34 | $0 (2024) |
| PFIZER INC. | $527.89 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,240 | 65 | AstraZeneca Pharmaceuticals LP ($649.72) |
| 2023 | $1,544 | 55 | AstraZeneca Pharmaceuticals LP ($365.10) |
| 2022 | $1,497 | 51 | AstraZeneca Pharmaceuticals LP ($376.97) |
| 2021 | $1,195 | 50 | Novo Nordisk Inc ($246.64) |
| 2020 | $485.80 | 28 | Merck Sharp & Dohme Corporation ($193.19) |
| 2019 | $1,832 | 105 | Janssen Pharmaceuticals, Inc ($249.08) |
| 2018 | $2,561 | 138 | AstraZeneca Pharmaceuticals LP ($420.71) |
| 2017 | $4,314 | 177 | AstraZeneca Pharmaceuticals LP ($713.20) |
All Payment Transactions
669 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: VACCINES | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $132.63 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: DIABETES | ||||||
| 11/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $36.83 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Oncology | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $114.00 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: PAIN | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Diabetes Care | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 282 | 425 | $82,200 | $33,580 |
| 2022 | 6 | 256 | 418 | $83,321 | $33,853 |
| 2021 | 7 | 277 | 442 | $85,223 | $37,631 |
| 2020 | 7 | 287 | 429 | $44,750 | $28,704 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 234 | $56,394 | $20,725 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $6,838 | $3,649 | 53.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 52 | $8,528 | $2,921 | 34.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 36 | $3,852 | $2,589 | 67.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 14 | 14 | $3,010 | $1,831 | 60.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $2,052 | $1,270 | 61.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $756.00 | $467.88 | 61.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $770.00 | $126.60 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 239 | $57,599 | $22,136 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 32 | 32 | $8,416 | $4,597 | 54.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 68 | $11,152 | $3,637 | 32.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 31 | 32 | $3,424 | $2,183 | 63.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 35 | $1,890 | $1,160 | 61.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $840.00 | $139.57 | 16.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 237 | $55,092 | $23,586 | 42.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 32 | 32 | $8,137 | $4,692 | 57.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 67 | $10,718 | $4,398 | 41.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 36 | 38 | $3,940 | $2,450 | 62.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 14 | $4,536 | $1,469 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 40 | 42 | $2,181 | $806.06 | 37.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 12 | 12 | $619.00 | $229.82 | 37.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 106 | 234 | $29,180 | $16,720 | 57.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 31 | 31 | $5,030 | $3,986 | 79.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 41 | 43 | $2,675 | $2,529 | 94.6% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 11 | 11 | $2,180 | $2,172 | 99.6% |
About Dr. David Kritz, MD
Dr. David Kritz, MD is a Family Medicine healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346376142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kritz, MD has received a total of $15,669 in payments from pharmaceutical and medical device companies, with $2,240 received in 2024. These payments were reported across 669 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($15,655).
As a Medicare-enrolled provider, Kritz has provided services to 1,102 Medicare beneficiaries, totaling 1,714 services with total Medicare billing of $133,768. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Orange, CA
- Active Since 02/26/2007
- Last Updated 07/10/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346376142
Products in Payments
- FARXIGA (Drug) $1,877
- JARDIANCE (Drug) $654.66
- XARELTO (Drug) $546.29
- INVOKANA (Drug) $515.14
- Repatha (Biological) $488.51
- MOUNJARO (Drug) $470.02
- JANUVIA (Drug) $465.40
- SHINGRIX (Biological) $456.02
- Impella (Device) $439.18
- BREZTRI (Drug) $427.14
- ENTRESTO (Drug) $354.43
- LifeVest (Device) $319.16
- Ozempic (Drug) $317.40
- TRULICITY (Drug) $295.34
- Prolia (Biological) $264.52
- Rybelsus (Drug) $263.87
- BYDUREON (Drug) $257.12
- VOQUEZNA (Drug) $255.83
- CHANTIX (Drug) $252.03
- MYRBETRIQ (Drug) $247.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Orange
Alpesh Amin, Md, MD
Family Medicine — Payments: $832,439
Desiree A Lie, Md, MD
Family Medicine — Payments: $64,035
Francis Gialanella, Md, MD
Family Medicine — Payments: $37,205
Dr. Anjani Kolahi, Md, MD
Family Medicine — Payments: $28,060
Giuseppe Salese, Md, MD
Family Medicine — Payments: $18,305
Dr. Calvin Parker, Md, MD
Family Medicine — Payments: $14,512